• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • Intense pulsed light therapy device registration in China – Guidelines amended

Intense pulsed light therapy device registration in China – Guidelines amended

Intense pulsed light therapy device
Thursday, 01 June 2023 / Published in Medical Device, News, NMPA Registration in China

Intense pulsed light therapy device registration in China – Guidelines amended

Intense pulsed light therapy device registration in China shall refer to the newly revised technical review guidelines issued (No.12 of 2023) by the China Centre for Medical Devices Evaluation (CMDE) on April 28, 2023.

Intense Pulsed Light (IPL) therapy has gained significant popularity in recent years as a non-laser treatment option for various skin conditions. As the demand for IPL therapy devices continues to grow, it becomes crucial especially for manufacturers to understand the registration process and requirements set by regulatory authorities in China.

The guidelines were revised by the CMDE with the objective to provide a more comprehensive guidance to registration applicants in China. These guidelines help standardize the development process of IPL therapy equipment, assist in preparing and writing registration application data, and offer valuable insights for the technical review department during the registration review process.

Scope

The guidelines apply to non-coherent, high-intensity pulsed light devices that utilize xenon lamps as the light source, with an output wavelength range typically between 400 nm and 1200 nm. These devices achieve the desired spectral output by coating the light guide crystal or inserting filters. According to the classification rules specified in YY 9706.257, these devices should be classified above exempted categories. Similar broad-spectrum non-coherent pulsed light devices with similar spectral ranges can also refer to these guidelines.

Key points for registration review

The guidelines cover important regulatory information such as product name, classification, coding, and management categories. It emphasizes the division of registration units based on technical structure, performance indicators, and intended use. Additionally, for imported products, documentation proving the listing of treatment heads or filters abroad is required.

Applicants are expected to describe the working principle, action mechanism, structure and composition, main functions, and unique features of the product. Detailed product descriptions, including diagrams and drawings, are necessary for each model.

The guidelines delve into the mechanism of action for IPL therapy devices. Selective photothermal action is the main theoretical basis for skin therapy, where IPL targets various chromophores such as melanin, oxyhemoglobin, and water. For IPL’s application in treating dry eye associated with meibomian gland dysfunction, the mechanism of action is based on photothermal effects and the reduction of inflammatory mediators on the ocular surface.

Intended use and user profile

Applicants must clearly define the intended use case scenarios and the target operators for their devices. Intense pulsed light therapy devices are commonly used in medical institutions. However, lower-power density handheld hair removal devices can also be used in home environments under professional guidance. For devices intended for home use, risk assessment should be conducted, considering factors such as device structure, duration of use, environmental conditions, and non-user exposure. Adequate safety mechanisms should be incorporated into the design to mitigate potential risks associated with foreseeable misuse or unconventional use.

Other important information

  • Structure and Composition:
    Detailed descriptions, circuit block diagrams, and specifications are required for each component. The guidelines outline the typical structure and composition of intense pulsed light therapy equipment, including the power supply device, control device, cooling device, reflective concentrator device, light source, light guide crystal, skin cooling device, protective glasses, and other components.
  • Product Categories:
    The guidelines categorize IPL therapy devices based on filtering modes, appearance structure (desktop or handheld), and wavelength ranges. Treatment heads may have short-wave cutoff or band-pass filtering modes, and devices can be either desktop or handheld.
  • Development History and Comparison:
    Applicants are encouraged to provide a development history of the proposed product, references to similar products, and comparisons with existing products in the market. This helps highlight innovation points, similarities, and differences between the declared product and other products on the market.

Further information

Read the original CMDE announcement on the amended technical review guidelines for intense pulsed light therapy device registration in China.

By adhering to the outlined requirements, manufacturers can ensure their products meet the necessary safety and performance standards. Also, Cisema can assist manufacturers in navigating the registration process effectively. Discover our services for medical device registration, renewals and NMPA Legal Agent.

GET IN TOUCH

🌐 Send us your enquiry
📚 Request our whitepapers
📣 Sign up for our newsletter

What you can read next

NMPA Essential Principles of Safety and Performance of Medical Devices
Overseas Innovative Medical Device Approved by NMPA via Green Channel
China Still Finalizing the Details for Self-Testing on Medical Devices

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • laser therapy devices

    Clinical evaluation of laser therapy devices – New guidelines issued

    Clinical evaluation of laser therapy devices ha...
  • dental implant system

    Clinical evaluation of dental implant systems in China – New guidelines issued

    Clinical evaluation of dental implant system ha...
  • China Medical Device Webinar

    China Medical Device Webinar with AdvaMed Accel for U.S. exporters

    The China Medical Device Webinar will be featur...
  • webinar_medical-device-market-authorisation

    Cisema presenting at FORUM Institut: Medical device marketing authorisation for advanced – Masterclass China

    Cisema is delighted to hold a Masterclass with ...
  • generative AI services

    China’s generative AI interim measures now in effect

    China’s generative AI interim measures fo...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP